Literature DB >> 35020078

Midterm osteolysis-induced aseptic failure of the M6-C™ cervical total disc replacement secondary to polyethylene wear debris.

Matthew Scott-Young1,2, Evelyne Rathbone3, Lauren Grierson4.   

Abstract

BACKGROUND: According to published meta-analyses, cervical total disc replacement (CTDR) seems to be superior to anterior cervical decompression and fusion (ACDF) in most clinical parameters. Despite short-term clinical success of CTDR, there are concerns regarding long-term durability of these prostheses.
METHODS: This prospective study involved 382 patients who received standalone CTDR or a hybrid procedure (ACDF/CTDR). A retrospective comparison between different CTDR devices was conducted regarding patient-reported outcome measures (PROMs), failure scenarios, and revision surgeries. The M6-C™ Artificial Cervical Disc (Orthofix, Lewisville, Texas) cohort was compared to the other CTDR devices clinically. Etiological reasons for revision, and the surgical technique of the revision was investigated.
RESULTS: Fifty-three patients received M6-C CTDR. Eighteen patients (34%) were revised at an average of 67 months postoperatively for wear-induced osteolysis. There were three additional cases of pending revision. The PROMs of the two groups were similar, indicating that the failure mode (wear-induced osteolysis) is often asymptomatic. The demographics of the two groups were also similar, with more women undergoing revision surgery than men. There were three one-level CTDR, four two-level hybrids, seven three-level hybrids, and three four-level hybrids revised anteriorly. Sixteen patients underwent removal of the prosthesis and were treated according to the extent of osteolysis. There were four vertebrectomies, six revisions to ACDF, and six revisions to another CTDR. One patient underwent supplemental fixation using a posterior approach. The other CTDR cohort had an incidence of 3.3% at the equivalent time, and none of these were due to osteolysis or wear-related events.
CONCLUSIONS: There is a concerning midterm failure rate related to ultra-high-molecular-weight-polyethylene wear-induced osteolysis in the M6-C. Patients implanted with the M6-C prosthesis should be contacted, informed, and clinically and radiologically assessed.
© 2022. The Author(s).

Entities:  

Keywords:  Cervical total disc replacement; M6-C prosthesis; Patient related outcome measures; Revision surgery; Wear-induced osteolysis

Mesh:

Substances:

Year:  2022        PMID: 35020078     DOI: 10.1007/s00586-021-07094-7

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   2.721


  26 in total

1.  Cervical total disc replacement with the Mobi-C cervical artificial disc compared with anterior discectomy and fusion for treatment of 2-level symptomatic degenerative disc disease: a prospective, randomized, controlled multicenter clinical trial: clinical article.

Authors:  Reginald J Davis; Kee D Kim; Michael S Hisey; Gregory A Hoffman; Hyun W Bae; Steven E Gaede; Ralph F Rashbaum; Pierce Dalton Nunley; Daniel L Peterson; John K Stokes
Journal:  J Neurosurg Spine       Date:  2013-09-06

2.  Five-year clinical results of cervical total disc replacement compared with anterior discectomy and fusion for treatment of 2-level symptomatic degenerative disc disease: a prospective, randomized, controlled, multicenter investigational device exemption clinical trial.

Authors:  Kris Radcliff; Domagoj Coric; Todd Albert
Journal:  J Neurosurg Spine       Date:  2016-03-25

3.  Prospective, randomized, multicenter study of cervical arthroplasty: 269 patients from the Kineflex|C artificial disc investigational device exemption study with a minimum 2-year follow-up: clinical article.

Authors:  Domagoj Coric; Pierce D Nunley; Richard D Guyer; David Musante; Cameron N Carmody; Charles R Gordon; Carl Lauryssen; Donna D Ohnmeiss; Margaret O Boltes
Journal:  J Neurosurg Spine       Date:  2011-06-24

4.  Long-term clinical and radiographic outcomes of the Prestige LP artificial cervical disc replacement at 2 levels: results from a prospective randomized controlled clinical trial.

Authors:  Todd H Lanman; J Kenneth Burkus; Randall G Dryer; Matthew F Gornet; Jeffrey McConnell; Scott D Hodges
Journal:  J Neurosurg Spine       Date:  2017-04-07

5.  A comparison of simulator-tested and -retrieved cervical disc prostheses. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.

Authors:  Paul A Anderson; Jeffrey P Rouleau; Jeffrey M Toth; K Daniel Riew
Journal:  J Neurosurg Spine       Date:  2004-09

6.  Cervical disc arthroplasty with PRESTIGE LP disc versus anterior cervical discectomy and fusion: a prospective, multicenter investigational device exemption study.

Authors:  Matthew F Gornet; J Kenneth Burkus; Mark E Shaffrey; Perry J Argires; Hui Nian; Frank E Harrell
Journal:  J Neurosurg Spine       Date:  2015-07-31

7.  Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease.

Authors:  Daniel Murrey; Michael Janssen; Rick Delamarter; Jeffrey Goldstein; Jack Zigler; Bobby Tay; Bruce Darden
Journal:  Spine J       Date:  2008-09-06       Impact factor: 4.166

8.  A systematic review of cervical artificial disc replacement wear characteristics and durability.

Authors:  Ronald Lehman; Adam J Bevevino; Devon D Brewer; Andrea C Skelly; Paul A Anderson
Journal:  Evid Based Spine Care J       Date:  2012-02

9.  Multi-center, prospective, randomized, controlled investigational device exemption clinical trial comparing Mobi-C Cervical Artificial Disc to anterior discectomy and fusion in the treatment of symptomatic degenerative disc disease in the cervical spine.

Authors:  Michael S Hisey; Hyun W Bae; Reginald Davis; Steven Gaede; Greg Hoffman; Kee Kim; Pierce D Nunley; Daniel Peterson; Ralph Rashbaum; John Stokes
Journal:  Int J Spine Surg       Date:  2014-12-01

10.  Results at 24 months from the prospective, randomized, multicenter Investigational Device Exemption trial of ProDisc-C versus anterior cervical discectomy and fusion with 4-year follow-up and continued access patients.

Authors:  Rick B Delamarter; Daniel Murrey; Michael E Janssen; Jeffrey A Goldstein; Jack Zigler; Bobby K-B Tay; Bruce Darden
Journal:  SAS J       Date:  2010-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.